Hemogenyx Pharmaceuticals Plc
Status: Publicly traded
Direct answer
Hemogenyx Pharmaceuticals Plc is publicly traded on LSE under the ticker HEMO.L.
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic...
Can you invest in Hemogenyx Pharmaceuticals Plc?
Yes. Hemogenyx Pharmaceuticals Plc is publicly traded on LSE under the ticker HEMO.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hemogenyx Pharmaceuticals Plc
Detailed equity research is provided by MarketSnap.